Expression of PDGF, VEGF and their receptors in non-small cell lung tumor cell lines

International Journal of Oncology

Volumn 9, Issue 5, 1996, Pages 1077-1086

  Holm, Christine ^a   Gineitis, Dziugas ^a,b   McConville, Glen S ^a   Kazlauskas, Andrius ^a,c  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b Institute of Biochemistry   (Lithuania)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

NSCLC; PDGF; VEGF

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0029909299     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.5.1077     Document Type: Article

References (72)

1. Minna JD, Pass H, Glatstein EJ and Ihde DC: Cancer of the lung. In: Principles and Practice of Oncology (eds.) V.T. DeVita, S. Hellman and S. Rosenberg. JB Lippincott, Philadelphia pp501-705, 1989.
2. Kelly K, Kane MA and Bunn PA Jr: Growth factors in lung cancer: Possible etiologic role and clinical target. Med Pediatric Oncol 19: 449-458, 1991.
3. Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A and Minna JD: Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 316: 823-826, 1985.
4. Shipp MA, Tarr GE, Chen C-Y, Switzer SN, Hcrsh LB, Stein H, Sunday ME and Reinherz EL: CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung. Proc Natl Acad Sci USA 88: 10662-10666, 1991.
5. Imanishi K-I, Yamaguchi K, Kuranami M, Kyo E, Hozumi T and Abe K: Inhibition of growth of human lung adenocarcinoma cell lines by anti-transforming growth factor-α monoclonal antibody. J Natl Cancer Inst 81: 220-223, 1989.
6. Aaronson SA: Growth factors and cancer. Science 247: 1146-1153, 1991.
7. Rodigues GA and Park M: Oncogenic activation of tyrosine kinases. Curr Opinion Genet Develop 4: 15-24, 1994.
8. Auffray C and Rougeon F: Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem 2: 303-314, 1994.
9. Gronwald RGK, Grant FJ, Haldeman BA, Hart CE, O'Hara PJ, Hagen FS, Ross R, Bowen-Pope DF and Murray MJ: Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: Evidence for more than one receptor class. Proc Natl Acad Sci USA 85: 3435-3439, 1988.
10. Matsui T, Heidaran M, Miki T, Popescu N, LaRochelle W, Kraus M, Pierce J and Aaronson S: Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science 243: 800-804, 1989.
11. Ruta M, Howk R, Ricca G, Drohan W, Zabelshansky M, Laureys G, Barton DE, Francke U, Schlessinger J and Givol D: A novel protein tyrosine kinase gene whose expression is modulated during endothelial cell differentiation. Oncogene 3: 9-15, 1988.
12. Coussens L, Van Beveren C, Smith D, Chen E, Mitchell RL, Isacke CM, Verman IM and Ulrich A: Structural alteration of viral homologue of receptor proto-oncogene fims at carboxy terminus. Nature 320: 277-280, 1986.
13. Rosnet O, Marchetto S, de Lapeyriere O and Birnbaum D: Murine Flt3, a gene encoding a novel tyrosine kinase receptor of hte PDGFR/CSF1R family. Oncogene 6: 1651-1650, 1991.
14. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL and Shows TB: Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6: 1677-1683, 1991.
15. Yarden Y, Kuang W-J, Yang-Fent T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U and Ulrich A: Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6: 3341-3351, 1987.
16. Takahashi M and Cooper GM: ret transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol Cell Biol 7: 1378-1385, 1987.
17. Kornbluth S, Paulson KE and Hanafuas H: Novel tyrosine kinase identified by phosphotyrosine antibody screening of cDNA libraries. Mol Cell Biol 8: 5541-5544, 1988.
18. Schwartz SM: Selection of characterization of bovine aortic endothelial cells. In Vitro 14: 966-980, 1978.
19. Seifert RA, Hart CE, Phillips PE, Forstrom JW, Ross R, Murray MJ and Bowen-Pope DF: Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem 264: 8771-8778, 1989.
20. Valius M and Kazlauskas A: Phospholipase C-γ1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell 73: 321-334, 1993.
21. Reddel RR, Ke Y, Gerwin BI, McMeanmin MG, Lechner JF, Su RT, Brash DE, Park J-B, Rhim JS and Harris CC: Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 48: 1904-1909, 1988.
22. Phelps RM, Johnson BE, Ihde DC, Gazdar AF, Carbone DP, McClintock PR, Linnoila RI, Matthews MJ, Bunn PA Jr, Carney D, Minna JD and Mulshine JL: NCI-Navy Medical Oncology Branch Cell Line Data Base. J Cell Biochem (Suppl) 24: 32-91, 1996.
23. Kazlauskas A, Kashishian A, Cooper JA and Valius M: GTPase-activating protein and phosphatidylinositol 3-kinase bind to distinct regions of the platelet-derived growth factor receptor ß subunit. Mol Cell Biol 12: 2534-2544, 1992.
24. Kazlauskas A and Cooper JA: Phosphorylation of the PDGF receptor ß subunit creates a tight binding site for phosphatidylinositol 3 kinase. EMBO J 9: 3279-3266, 1990.
25. Bazenet C and Kazlauskas A: The PDGF receptor alpha subunit activates p21ras and triggers DNA synthesis without interacting with rasGAP. Oncogene 9: 517-525, 1994.
26. Pettijohn DE, Pfenninger O, Brown J, Duke R and Olsson L: Tumorigenic human squamous lung cancer cells have defined cell surface carbohydrates that are absent from nontumorigenic cells. Proc Natl Acad Sci USA 85: 802-806, 1988.
27. Burgess WH and Maciag T: The herparin-binding (fibroblast) growth factor family of proteins. Ann Rev Biochem 58: 575-606, 1989.
28. Oelrichs RB, Reid HH, Bernard O, Ziemiecki A and Wilks AF: A putative receptor protein tyrosine kinase isolated from ElO embryonic neuroepithelium is expressed in endothelial cells of the developing embryo. Oncogene 8: 11-18, 1993.
29. Heldin C-H, Westermark B and Wasteson A: Specific receptors for platelet-derived growth factor on cells derived from connective tissue and glia. Proc Natl Acad Sci USA 78: 3664-3668, 1981.
30. Matthews W, Jordan CT, Gavin M, Jenkins NA, Copeland NG and Lemischka IR: A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci USA 88: 9026-9030, 1991.
31. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowica D and Böhlen P: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187: 1579-1586, 1992.
32. Ferrara N, Houck K, Jakeman L and Leung DW: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endothel Rev 13: 18-32, 1992.
33. Baserga R: Oncogenes and the strategy of growth factors. Cell 79: 927-930, 1994.
34. Myoken Y, Kayada Y, Okamuto T, Kan M, Sato GH and Sato JD: Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc Natl Acad Sci USA 88: 5819-5823, 1991.
35. Plate KH, Breier G, Millauer B, Ullrich A and Risau W: Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor anciogenesis. Cancer Res 53: 5822-5827, 1993.
36. Collins T, Ginsburg D, Boss JM, Orkin SH and Pober JS: Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis. Nature 316: 748-750, 1985.
37. Do M-S, Fitzer-Attas C, Gubbay J, Greenfield L, Feldman M and Eisenbach L: Mouse platelet-derived growth factor α receptor: sequence, tissue-specific expression and correlation with metastatic phenotype. Oncogene 7: 1567-1575, 1992.
38. Valius M, Bazenet C and Kazlauskas A: Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor ß subunit and are required for binding of phospholipase Cγ and a 64-kilodalton protein, respectively. Mol Cell Biol 13: 133-143, 1993.
39. Fantl WJ, Escobedo JA, Martin GA, Turck CT, del Rosario M, McCormick F and Williams LT: Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell 69: 413-423, 1992.
40. Matsui T, Pierce JH, Fleming TP, Greenberger JS, LaRochelle WJ, Ruggiero M and Aaronson SA: Independent expression of human α or ß platelet-derived growth factor receptor cDNAs in a naive hematopoietic cell leads to functional coupling with mitogenic and chemotactic signaling pathways. Proc Natl Acad Sci USA 86: 8314-8318, 1989.
41. Sariban E, Sitaras NM, Antoniades HN, Kufe DW and Pantazis P: Expression of platelet-derived growth factor (PDGF)-related transcripts and synthesis of biologically active PDGF-like proteins by human malignant epithelial cell lines. J Clin Invest 82: 1157-1164, 1988.
42. Antoniades HN, Bravo MA, Avila RE, Galanopoulos T, Neville-Golden J, Maxwell M and Selman M: Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest 86: 1055-1064, 1990.
43. Bergh J: The expression of the platelet-derived and transforming growth factor genes in human non-small lung cancer cell lines is related to tumor stroma formation in nude mice tumors. Amer J Pathol 133: 434-439, 1988.
44. Antoniades HN, Galanopoulos T, Neville-Golden J and O'Hara CJ: Malignant epithelial cells in primary human lung carcinomas coexpress in vivo platelet-derived growth factor (PDGF) and PDGF receptor mRNAs and their protein products. Proc Natl Acad Sci USA 89: 3942-3946, 1992.
45. Devare SG, Reddy EP, Law JD, Robbins KC and Aaronson SA: Nucleotide sequence of the simian sarcoma virus genome: Demonstration that its acquired cellular sequences encode the transforming gene product p28sis. Proc Natl Acad Sci USA 80: 731-735, 1983.
46. Josephs SF, Ratner L, Clarke MF, Westin EH, Reitz MS and Wong-Staal F: Transforming potential of human c-sis nucleotide sequences encoding platelet-derived growth factor. Science 225: 636-639, 1984.
47. Waterfield MD, Scrace GT, Whittle N, Stroobant P, Johnsson A, Wasteson A, Westermark B, Heldin C-H, Huang JS and Deuel TF: Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature 304: 35-39, 1983.
48. Clarke MF, Westin E, Schmidt D, Josephs SF, Ratner L, Wong-Staal F, Gallo RC and Reitz MD Jr: Transformation of NIH 3G3 cells by a human c-sis cDNA clone. Nature 308: 464-467, 1984.
49. Gazit A, Igarashi H, Chiu I-M, Srinivasan A, Yaniv A, Tronick SR, Robbins KC and Aaronson SA: Expression of the normal human sis/PDGF-2 coding sequence induces cellular transformation. Cell 39: 89-97, 1984.
50. Plate KH, Brier G, Farrell CL and Risau W: Platelet-derived growth factor receptor-ß is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas. Lab Investigat 67: 529-534, 1992.
51. Hermansson M, Nister M, Betsholtz C, Heldin C-H, Westermark B and Funa K: Endothelial cell hyperplasia in human glioblastoma: Coexpression of mRNA for platelet-derived growth factor (PDGF) ß chain and PDGF receptor suggests autocrine growth stimulation. Proc Natl Acad Sci USA 85: 7748-7752, 1988.
52. Harsh RG, Keating MT, Escobedo JA and Williams LT: Platelet-derived growth factor (PDGF) autocrine components in human tumor cell lines. J Neuro-Oncol 8: 1-12, 1990.
53. Leveen P, Claesson-Welsh L, Heldin C-H, Westermark B and Betsholtz C: Expression of messenger RNAs for platelet-derived growth factor and its receptors in human sarcoma cell lines. Int J Cancer 46: 1066-1070, 1990.
54. Nister M, Libermann TA, Betsholtz C, Pettersson M, Claesson-Welsh L, Heldin C-H, Schlessinger J and Westermark B: Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-α and their receptors in human malignant glioma cell lines. Cancer Res 48: 3910-3918, 1988.
55. Maxwell M, Galanopoulos T, Hedley-Whyte ET, Black PM and Antoniades HN: Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products. Cancer 46: 16-21, 1990.
56. Betsholtz C, Westermark B, Ek B and Heldin C-H: Coexpression of a PDGF-like growth factor and PDGF receptors in a human osteosarcoma cell line: implications for autocrine receptor activation. Cell 39: 447-457, 1984.
57. Vassbotin FS, Andersson M, Westermark B, Heldin C-H and Österman A: Reversion of autocrine transformation by a dominant negative platelet-derived growth factor mutant. Mol Cell Biol 13: 4066-4076, 1993.
58. Shamah SM, Stiles CD and Guhu A: Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells. Mol Cell Biol 13: 7203-7212, 1993.
59. Nilson LA and DiMaio D: Platelet-derived growth factor receptor can mediate tumorigenic transformation by the bovine papillomavirus E5 protein. Mol Cell Biol 13: 4137-4145, 1993.
60. Fitzer-Attas C, Feldman M and Eisenbach L: Expression of functionally intact PDGF-α receptors in highly metastatic 3LL Lewis lung carcinoma cells. Int J Cancer 53: 315-322, 1993.
61. Mustonen T and Alitalo K: Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 129: 895-898, 1995.
62. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N and Alitalo K: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15: 290-298, 1996.
63. Olofsson B, Pajusola K, Kaipainen A, von Euler G, Joukov V, Saksela O, Orpana A, Pettersson RF, Alitalo K and Eriksson U: Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 93: 2576-2581, 1996.
64. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu X-F, Breltman ML and Schuh AC: Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66, 1995.
65. Fong G-H, Rossant J, Gertsenstein M and Breitman ML: Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70, 1995.
66. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ and Moore MW: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442, 1996.
67. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W and Nagy A: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439, 1996.
68. Millauer B, Shawver LK, Plate KH, Risau W and Ullrich A: Glioblastoma growth inhibited in vivo by a dominant-negative flk-1 mutant. Nature 367: 576-579, 1994.
69. Kim KJ, Li B, Winer J, Aramanini M, Gillett N, Phillips HS and Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362: 841-844, 1993.
70. Shweiki D, Itin A, Soffer D and Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992.
71. Tuder RM, Flook BE and Voelkel NF: Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. J Clin Invest 95: 1798-1807, 1995.
72. Cao Y, Chen H, Zhou L, Chiang M-K, Anand-Apte B, Weatherbee JA, Wang Y, Fang F, Flannagan JG and Tsang ML: Heterodimers of placenta growth factor/fascular endothelial growth factor. J Biol Chem 271: 3154-3162, 1996.